Health & Wellness
09/16/2026 · Eclectic
FDA Approves New Pancreatic Cancer Drug Rasonque
The U.S. Food and Drug Administration approved Rasonque, a RAS inhibitor, for advanced pancreatic cancer. This decision provides a new treatment option for patients earlier than anticipated.
FDA Authorizes First Device to Continuously Monitor Glucose and Ketones
The U.S. Food and Drug Administration has authorized the first wearable device that continuously monitors both ketone levels and blood sugar. The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System received approval for use by individuals aged two years and older living with diabetes.
09/13/2026 · Alabama
Peer-Reviewed Study Reports on New Blood Test for Early Breast Cancer Detection
A new peer-reviewed study details a blood test for early-stage breast cancer, reporting over 92% sensitivity and specificity. Researchers indicate the test's performance surpasses current supplemental screening methods. The study comes from a team at Astrin Biosciences.
08/23/2026 · Alabama
FDA Approves Subcutaneous Lecanemab for Early Alzheimer's Treatment
The Food and Drug Administration has approved LEQEMBI IQLIK (lecanemab-irmb), a subcutaneous injection for early Alzheimer's disease. This formulation allows for at-home dosing, broadening administration options for patients.
08/21/2026 · Alabama
Survey Identifies Generational Differences in Healthcare System Perceptions
A recent national survey reveals differences in how age groups perceive the U.S. healthcare system. Gen Z and Millennial voters more frequently identified systemic failures, especially regarding women's health services.
08/21/2026 · Alabama
FDA Approves Subcutaneous Leqembi Starting Dose for Alzheimer's Treatment
The FDA has approved a weekly subcutaneous starting dose for Leqembi, a drug for early Alzheimer's. This approval provides an alternative administration method for patients. The Alzheimer's Drug Discovery Foundation commented on the development.
08/19/2026 · Alabama
Advertisement
Upcoming Events
View allSEP
19
Florida St. at Alabama
19:30
SEP
19
Miles at Clark Atlanta
22:00
SEP
19
Bowie St. at Alabama A&M
22:00
Announcements
View allAG to Host Forum on Opioid Crisis; Community Input Sought
In response to the critical and ongoing opioid crisis impacting Alabama, Attorney General [Insert AG Name Here] will host a public forum. This important gathering is intended to foster open dialogue and collaborative action. The forum will feature presentations from experts in addiction treatment, law enforcement officials addressing interdiction efforts, and community advocates. The goal is to raise awareness, provide vital information on available resources, and discuss strategies for prevention and recovery within our communities. Details regarding the date, time, and location of the forum will be announced shortly on the official website.
Public Hearing Announced for New Regulations by AG's Office
NOTICE IS HEREBY GIVEN that the Alabama Attorney General's office will hold a public hearing concerning proposed regulations pertaining to [specific area of regulation, if mentioned in original content]. The hearing is scheduled for [Date] at [Time] in the [Location/Room Number] at the Attorney General's office, [Address]. Written comments will also be accepted until [Date]. Further details and the full text of the proposed regulations are available on our website.
Alabama AG Website Sitemap Available
This is the sitemap for the Alabama Attorney General's website. It contains links to various pages and resources for users to access information. The sitemap is organized into multiple parts for better navigation.
Advertisement
Advertisement